News
Dr. Shaun K. Olsen receives UT System award to discover innovative solutions to health problems
September 2, 2021
Shaun K. Olsen, PhD, has been awarded a $1 million UT System Faculty STARs award to conduct innovative research to better understand the molecular mechanisms of diseases and advance drug discovery efforts for treatment.
Neonatologist to lead clinical trial for early diagnosis of lung disease in newborns
August 31, 2021
Alvaro Moreira, MD, MSc, neonatologist and assistant professor of pediatrics at UT Health San Antonio’s Joe R. and Teresa Lozano Long School of Medicine, received a $652,000 mentored career development grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Dr. Moreira will investigate a novel approach to diagnosing bronchopulmonary […]
UT Health San Antonio and affiliated researchers awarded $23 million in latest CPRIT funding cycle
August 24, 2021
Cancer research at UT Health San Antonio is getting a $23 million boost from the Cancer Prevention and Research Institute of Texas (CPRIT).
In JAMA commentary, UT Health San Antonio authors urge uplifting U.S. Latinos to improve health and our nation
August 19, 2021
Despite accounting for more than 18% of the U.S. population, “the Latino community has not benefited from having ‘presence’ in the U.S. health care workforce through meaningful and influential administrative and governance positions,” they wrote.
New paper provides a link between common chemicals and ‘unexplained’ chronic illnesses
July 28, 2021
Could your new home with its fresh paint, carpet and cabinets, as well as pesticides used around the place, cause a range of illnesses due to chemical intolerance? A new paper provides a long-awaited link between exposures to common chemicals and so-called unexplained illnesses. It also for the first time asserts a mechanism for the how and why this […]
Can a vitamin treat COVID-19-related acute kidney injury?
July 27, 2021
Researchers at UT Health San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have launched NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury (AKI) in COVID-19 patients.
Team describes science-based hiccups intervention
July 8, 2021
Researchers from UT Health San Antonio and colleagues worldwide describe a new science-based intervention for hiccups in a research letter published in the journal JAMA Network Open.
LINC Seed Grant awards support pilot projects to foster innovations in interprofessional education
June 18, 2021
The annual Linking Interprofessional Networks for Collaboration (LINC) Seed Grant Program encourages faculty and staff to develop novel interprofessional education (IPE) activities and promotes IPE research and scholarship.
Novavax vaccine is highly protective against COVID-19 in Phase 3 results
June 17, 2021
UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19.
Metal ions help COVID-19 virus to disguise itself
June 2, 2021
Scientists from The University of Texas Health Science Center at San Antonio have discovered a mechanism by which SARS-CoV-2 exploits changes in metal ion concentrations to disguise itself in the body. Varying concentrations of metal ions — positively charged atoms such as magnesium, manganese and calcium — are observed in hospitalized COVID-19 patients.